Tigress Financial Maintains Buy on Legence, Raises Price Target to $130
Tigress Financial analyst Ivan Feinseth maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $125 to $130.
Read original at benzingaStocks · News reference
Roth Capital Reiterates Buy on Legence, Maintains $120 Price Target
Roth Capital analyst Craig Irwin reiterates Legence (NASDAQ:LGN) with a Buy and maintains $120 price target.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Aug 12, 2026, 5:55 PM
- Checked
- Aug 12, 2026, 5:55 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Legence Corp. (LGN)
Filed: 2026-08-18 AccNo: 0001193125-26-355583 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits
Read original at edgarGuggenheim Reiterates Buy on Legence, Maintains $115 Price Target
Guggenheim analyst Joseph Osha reiterates Legence (NASDAQ:LGN) with a Buy and maintains $115 price target.
Read original at benzingaB of A Securities Maintains Buy on Legence, Raises Price Target to $116
B of A Securities analyst Sherif El-Sabbahy maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $105 to $116.
Read original at benzinga